"The
Report Global Anticoagulant Market 2017-2021 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz
has added a new report to its repository, titled, “Global
Anticoagulant Market 2017-2021.”
The report examines the market in-depth to understand its size and
scope. It also sheds light on the current competitive dynamics in the
market.
The
report predicts the global anticoagulant market to clock a healthy
CAGR of 7.42% from 2017 to 2021.
Anticoagulants
thwart clot formations and also help prevent enlargement of existing
clots in the arteries or veins. Some of the anticoagulants available
in the market are heparins, including unfractionated heparin (UFH)
and low molecular weight heparin (LMWH); factor Xa inhibitors; and
vitamin K antagonists. They are used for indications such as angina,
heart attack, deep venous thrombosis (DVT), stroke, pulmonary
embolism (PE), surgery, dialysis, atrial fibrillation (AF),
thrombocytopenia, and myocardial infarction.
The
report finds that robust demand for novel oral anticoagulant (NOACs)
has been at the forefront of driving demand in the global market for
anticoagulants. NOACs target either thrombin or factor Xa to thwart
and cure thrombosis. They act fast and do not require continued
monitoring. They are also safer and more effective, compared to
conventional therapies such as warfarin.
Other
factors driving the market are the rising prevalence of coagulation
disorders and growth in hip and knee surgeries. Countering the growth
in the market, on the other hand, is the steep cost of NOACs and
dearth of antidotes in the market for NOACs. Patent expiries paving
the way for generics will also likely impede the market’s growth in
the near future. Some of the noticeable trends in the market are
different patient assistance programs gaining traction.
Get
Sample Copy Of This Report @
Having
discussed the growth drivers, restraints, and current trends, the
report goes on to segment the market based on different parameters
and study each segment in details. Based on application, it
classifies the market into DVT, AF, PE, etc. Depending upon ROA, the
global market for anticoagulant can be further divided into oral
anticoagulants and injectable anti-coagulants.
Geography-wise,
the key segments analyzed in the report are the Americas, the Asia
Pacific, and the Europe, Middle East, and Africa. Among them, the
Americas hold a dominant position in terms of market share and will
continue doing so in the next few years on account of the swift pace
of introduction of NOACs.
View
Press Release @
http://www.marketresearchreports.biz/pressrelease/4034
To
assess the competition prevailing in the global anticoagulant market,
the report leverages Porter’s Five Forces analysis. It finds that
astute players are increasingly focusing on strategic alliances to
bolster their positions in the market and also increasingly looking
to make inroads into the lucrative developing market’s economies.
Some of the key players operating in the market that have been
profiled in the report include Bristol-Myers Squibb, Bayer
HealthCare, Daiichi Sankyo, Sanofi, Boehringer Ingelheim, and Johnson
& Johnson.
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment